Back to All Events

In Conversation with IBioIC CEO Mark Bustard

Fireside chat EVENTBRITE.jpg

About this Event

IBioIC’s Senior Business Engagement Manager Caroline Kewney will interview IBioIC’s CEO Mark Bustard for a virtual fireside chat that reviews IBioIC’s 2020 activity and what the network can expect in 2021 . Conversation topics will range from COVID-19, the green recovery and how IBioIC has supported its members during this time, to steering and leading an organisation as a newly appointed CEO during a pandemic.

15.00 – 15.05 Welcome and introduction

15.05 – 15.40 Interview with CEO Mark Bustard

15.40 – 15.55 Q&A with the audience

15.55- 16.00 Event to close

Attendees will have the opportunity to submit questions in advance via registration, alternatively please send your questions via email to Debbie McCreath, IBioIC’s Public Affairs Manager (debbie.mccreath@ibioic.com). The event will be held via Zoom, and the joining instructions will be sent in a confirmation email.


Mark Bustard, CEO, IBioIC

 
Mark Bustard copy.jpeg
 

Mark took over as CEO in February 2020, having previously been IBioIC's Commercial Director. In that role, he led the commercial strategy in identifying and securing opportunities IBioIC to engage, collaborate with and support large corporates, SMEs, academia and Government to accelerate and de-risk commercialisation, and to bring new biotechnology processes and products to the global market.

Mark joined IBioIC from CPI where he was Business Development Director for the National Biologics Manufacturing Centre in Darlington, a £38M facility for the rapid development, scale-up and characterisation of complex biologic therapeutics, vaccines and viral vectors. Prior to this he was the Medicines Manufacturing Specialist at the Knowledge Transfer Network (KTN), Technical Director for Medicines at the previous HealthTech and Medicines KTN and worked for seven years developing the growth of bioprocessing across the UK as part of bioProcessUK. In these roles he assisted companies build collaborations, raised awareness of funding opportunities and made academic links as appropriate for their business needs. During this time Mark has also been a steering group member for the Medicines Manufacturing Industry Partnership and has recently led the secretariat function for the Advanced Therapies Manufacturing Taskforce.

For the last five years he was also the Programme Coordinator for the Bioprocessing Research Industry Club (BRIC), a BBSRC led research club supported by EPSRC, KTN and member companies.

Prior to joining KTN, he held senior positions in academia being the Director of Research for Chemical Engineering and Lecturer in Bioprocessing at Heriot-Watt University, Edinburgh. Mark has also worked in biomanufacturing, development and consultancy with Biopharm Services and in delivering projects across Biopharmaceuticals, Pharmaceuticals, Industrial Biotechnology and Food and Drink sectors.


Caroline Kewney, Senior Business Engagement Manager, IBioIC

Caroline+Kewney+480x370.jpg

Caroline joined the commercial team at IBioIC as Senior Business Engagement Manager in April 2020, bringing over 25 years of biotechnology industry experience to the team. Her expertise lies in providing biosafety testing, process validation and biomanufacturing support to researchers, small biotech companies and large pharma in their quest to develop novel biopharmaceuticals at all stages of their journey from R&D, through clinical trials and onto market.

Caroline originally trained as a virologist, before moving into commercial roles in Sales & Marketing, Business Development, and Client/Project Management within a range of contract testing organisations within Scotland, including BioReliance, BioOutsource and SGS, as well as a period relocating to the US to set a subsidiary of Q-One Biotech to serve US and Canadian customers. She has extensive experience supporting a range of clients globally and working closely with regulatory bodies across European, Asian and US markets.

Caroline graduated from the University of Glasgow with a BSc (Hons) in Biochemistry and a Masters in biotechnology researching retroviral vector biomanufacturing and biosafety testing. She also has a BSc (Hons) in Psychology from The Open University.